Chief Strategy & Transformation Officer
Fresenius Medical Care North America
Jeff Burbank has been chief executive officer and a director of NxStage since he founded the company in 1998. He has more than thirty years of in-depth management experience with companies developing, marketing, and manufacturing products for end-stage renal disease (ESRD) patients. He has led NxStage since its inception, guiding it through all of its developmental phases to the successful initiation and rapid growth of commercial activities, its initial public offering, and the acquisition of Medisystems Corporation, the evolution of the product line, and entry into services. Prior to founding NxStage, Jeff cofounded Vasca, Inc., a company providing innovative implantable access devices, where he was president and chief executive officer, as well as chairman of its board of directors. He gained significant renal industry experience during his nine years in the renal division at Gambro, Inc., a medical technology company, where his last position was director of marketing and Advanced Technologies. During his career, Jeff has been an inventor on more than fifty US patents for medical devices. He brings entrepreneurial skill, leadership, and technical and medical device experience in the renal dialysis industry to the board.